Brent Jones - Avantor Executive CFO

AVTR Stock  USD 20.78  0.42  2.06%   

CFO

Brent Jones is Executive CFO of Avantor
Age 54
Address Radnor Corporate Center, Radnor, PA, United States, 19087
Phone610 386 1700
Webhttps://www.avantorsciences.com

Avantor Management Efficiency

The company has return on total asset (ROA) of 0.0327 % which means that it generated a profit of $0.0327 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0581 %, meaning that it created $0.0581 on every $100 dollars invested by stockholders. Avantor's management efficiency ratios could be used to measure how well Avantor manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Avantor's Return On Tangible Assets are relatively stable compared to the past year. As of 11/22/2024, Return On Assets is likely to grow to 0.03, while Return On Capital Employed is likely to drop 0.04. At this time, Avantor's Intangible Assets are relatively stable compared to the past year. As of 11/22/2024, Non Currrent Assets Other is likely to grow to about 206.1 M, while Net Tangible Assets are likely to drop (4.7 B).
Avantor currently holds 5.54 B in liabilities with Debt to Equity (D/E) ratio of 1.46, which is about average as compared to similar companies. Avantor has a current ratio of 1.61, which is within standard range for the sector. Note, when we think about Avantor's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 6 records

CFO Age

Susan KrehOil Dri
62
Carl IIAxalta Coating Systems
54
Tom ColerQuaker Chemical
N/A
Erik AldagMinerals Technologies
39
Ian CleminsonInnospec
59
Erica CPACabot
47
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania. Avantor operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 13500 people. Avantor (AVTR) is traded on New York Stock Exchange in USA. It is located in Radnor Corporate Center, Radnor, PA, United States, 19087 and employs 14,500 people. Avantor is listed under Life Sciences Tools & Services category by Fama And French industry classification.

Management Performance

Avantor Leadership Team

Elected by the shareholders, the Avantor's board of directors comprises two types of representatives: Avantor inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avantor. The board's role is to monitor Avantor's management team and ensure that shareholders' interests are well served. Avantor's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avantor's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jonathan Peacock, Lead Independent Director
Joseph Massaro, Independent Director
Christophe MBA, Executive AMEA
Lan Kang, Independent Director
Tanya Foxe, Executive Vice President - Global Operations and Supply Chain
Thomas Szlosek, Chief Financial Officer, Executive Vice President
Matthew Holt, Independent Director
Brittany Hankamer, Executive Officer
Brent Jones, Executive CFO
Mala Murthy, Independent Director
Mark Murray, Executive Vice President of the Biomaterials and Advanced Technologies Platform
John Carethers, Independent Director
Steven Eck, Senior Vice President Chief Accounting Officer
Juan Andres, Independent Director
James Bramwell, Executive Vice President, Avantor Services, Strategic Partners
Randy Stone, Executive Solutions
Christi Shaw, Independent Director
Benoit Gourdier, Executive Production
Sven Henrichwark, Executive Vice President of APAC
Allison Hosak, Senior Brand
Tommy CPA, Vice Relations
Sheri Lewis, Executive Vice President Global Operations and Supply Chain
Christina Jones, Vice Relations
Gerard Brophy, Executive Vice President - Biopharma Production
Rakesh Sachdev, Independent Director
Devashish Ohri, Executive Vice President - AMEA
Kitty Sahin, Executive Development
Michael Wondrasch, Executive Vice President, Chief Information Officer
Gregory Summe, Independent Director
Andre Moura, Director
Tommy Thomas, Vice President – Investor Relations
Frederic Vanderhaegen, Executive Vice President - Americas and Europe
Justin Esq, Gen VP
Claudius Sokenu, Corporate VP
Meghan Henson, Chief Human Resource Officer, Executive Vice President
Justin Miller, Executive Vice President General Counsel, Secretary
Rajiv Gupta, Non-Executive Chairman of the Board
Eric McAllister, Chief Human Resource Officer, Executive Vice President
Jo Natauri, Director
Michael Stubblefield, President, Chief Executive Officer, Director
Michael Severino, Independent Director
Christophe Couturier, Executive Vice President - Services, Strategy and Business Transformation

Avantor Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avantor a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Avantor

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avantor position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avantor will appreciate offsetting losses from the drop in the long position's value.

Moving together with Avantor Stock

  0.7A Agilent Technologies Earnings Call This WeekPairCorr
  0.9ME 23Andme HoldingPairCorr
  0.66VALN Valneva SE ADRPairCorr

Moving against Avantor Stock

  0.85BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.83EXEL ExelixisPairCorr
  0.67EWTX Edgewise TherapeuticsPairCorr
  0.42KTTAW Pasithea TherapeuticsPairCorr
The ability to find closely correlated positions to Avantor could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avantor when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avantor - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avantor to buy it.
The correlation of Avantor is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avantor moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avantor moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avantor can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Avantor Stock Analysis

When running Avantor's price analysis, check to measure Avantor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avantor is operating at the current time. Most of Avantor's value examination focuses on studying past and present price action to predict the probability of Avantor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avantor's price. Additionally, you may evaluate how the addition of Avantor to your portfolios can decrease your overall portfolio volatility.